HER2 Support Group Forums - Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage br

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- General Cancer News (https://her2support.org/vbulletin/forumdisplay.php?f=45)

- - Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage br (https://her2support.org/vbulletin/showthread.php?t=58478)

News	07-01-2013 11:47 PM

Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage br

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application for the use of a Perjeta (pertuzumab) regimen before surgery (neoadjuvant treatment) in people with HER2-positive early stage breast cancer.

More...

karen z

07-02-2013 10:10 AM

Re: Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stag

Interesting as are many of the news postings today.

'lizbeth

07-03-2013 02:40 PM

Re: Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stag

Does anyone know if the neoadjuvant treatment is solely Perjeta without chemo, and what do they consider early stage? Is it tumor size below 1cm?

All times are GMT -7. The time now is 09:31 PM.